Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.785
0.00 (0.00%)
May 21, 2026, 10:52 AM CET
Pila Pharma AB Revenue
In the year 2025, Pila Pharma AB had annual revenue of 1.13M SEK with 42.65% growth. Pila Pharma AB had revenue of 275.74K in the half year ending December 31, 2025, a decrease of -24.67%.
Revenue
1.13M
Revenue Growth
+42.65%
P/S Ratio
72.37
Revenue / Employee
1.13M
Employees
1
Market Cap
81.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13M | 336.85K | 42.65% |
| Dec 31, 2024 | 789.89K | -673.13K | -46.01% |
| Dec 31, 2023 | 1.46M | -417.72K | -22.21% |
| Dec 31, 2022 | 1.88M | 1.16M | 161.49% |
| Dec 31, 2021 | 719.23K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 287.55M |
| IRLAB Therapeutics AB | 92.46M |
| Alzinova AB | 25.66M |
| Scandinavian ChemoTech AB | 12.61M |
| Biovica International AB | 10.93M |
| AcouSort AB | 10.43M |
| NextCell Pharma AB | 9.83M |
| Spago Nanomedical AB | 4.38M |
Pila Pharma AB News
- 9 months ago - Pila Pharma AB Earnings Call Transcript: Q2 2025 - Transcripts
- 11 months ago - Pila Pharma AB Transcript: Investor Update - Transcripts